News overview

Regmed XB and DCVA valorisation community event: Scaling and Manufactoring

RegMed XB and DCVA invited scientists and other interested parties came together at their valorisation community event 'Scaling and Manufacturing'. The event took place at the NexstGen facilitiy in Leiden, which is part of the RegMed XB pilot factory.

Recommended read: (Bio)fabrication of microfluidic devices and organs-on-a-chip

Last summer, Yang Li, a scientist from the ICAT team, contributed to a chapter in 3D Printing in Medicine Second Edition. The book examines the rapidly growing market of 3D-printed biomaterials and their clinical applications.

International Conference on Biofabrication 2022

This September, our ICAT team attended the annual International Conference on Biofabrication that took place in Tuscany. The conference, led by the International Society for Biofabrication, aims to bring together leading academic scientists and researchers to exchange and share their know-how and results on all aspects of Biofabrication.

RegMed XB awarded 56 million euros from National Growth Fund

Today, the Dutch cabinet decided to fully fund the National Growth Fund application of RegMed XB. A maximum of 56 million euros will be available for setting up a pilot plant for regenerative medicine.